Fig 7. Effects of Ac-SDKP on cardiac interleukin 1β (IL-1β) and endogenous tissue inhibitors of metalloproteinases (TIMP-1).

A) IL-1β was measured by ELISA at 48 hours post-myocardial infarction (MI). There was a significant increase in IL-1β expression in MI. Ac-SDKP did not prevent increased in IL-1β. B) Measurement of TIMP-1 at 48 hours post-MI by ELISA indicated that the increase in TIMP-1 in MI is reduced by Ac-SDKP.